20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9399 | Menin-MLL inhibitor 20 | Epigenetic Reader Domain , Histone Methyltransferase | |
Menin-MLL inhibitor 20 is an irreversible inhibitor of menin-MLL interaction with antitumor activities. | |||
T2649 | Menin-MLL inhibitor MI-2 | Menin-MLL Inhibitor,MI2,MI-2,Menin-MLL inhibitor 2,MI 2 | Apoptosis , Epigenetic Reader Domain , Histone Methyltransferase |
Menin-MLL inhibitor MI-2 (MI2) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM. | |||
T2643 | MI-3 | Menin-MLL Inhibitor,Menin-MLL inhibitor 3,MI 3 | Apoptosis , Epigenetic Reader Domain , Histone Methyltransferase |
MI-3 (Menin-MLL Inhibitor) (Menin-MLL Inhibitor) is an effective inhibitor of Menin-MLL interaction (IC50: 648 nM). | |||
T69629 | M‑89 MLL inhibitor | ||
M‑89 is a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein−Protein Interaction (Kd = 1.4 nM; IC50 = 25nM). M-89 binds to menin with a Kd value of 1.4 nM and effectively engages cellular men... | |||
T12002 | Menin-MLL inhibitor 4 | Others | |
Menin-MLL inhibitor 4 has antitumor activity.Menin-MLL inhibitor 4 is an inhibitor of Menin- MLL (mixed-lineage leukemia protein) interaction . | |||
T79737 | Menin-MLL inhibitor 29 | Epigenetic Reader Domain | |
Menin-MLL Inhibitor 29 (Compound C1) is a Menin-MLL protein-protein interaction (PPI) inhibitor that demonstrates high affinity to Menin with a dissociation constant (K D) of 138 nM and impedes Menin's interaction with M... | |||
T78151 | Bleximenib oxalate | Menin-MLL inhibitor 24 oxalate | Epigenetic Reader Domain |
Menin-MLL Inhibitor 24 (compound A) oxalate, a menin-mixed-lineage leukemia 1 (menin-MLL) inhibitor, is utilized in cancer research [1]. | |||
T72360 | Menin-MLL inhibitor 26 | ||
Menin-MLL inhibitor 26 is a Menin-MLL inhibitor. Menin-MLL inhibitor 26 also is an active reference. Menin-MLL inhibitor 26 can inhibits cell growth. Menin-MLL inhibitor 26 can be used for the research of leukemia . | |||
T79117 | Menin-MLL inhibitor 27 | Epigenetic Reader Domain | |
Menin-MLL inhibitor 27 effectively inhibits the interaction between Menin and MLL, serving as a potential tool in cancer research, particularly for acute myeloid leukemia (AML) [1]. | |||
T72135 | (1s,4s)-Menin-MLL inhibitor-23 | ||
(1s,4s)-Menin-MLL Inhibitor-23, an enantiomer of Menin-MLL Inhibitor-23 (Example 99A), functions as an inhibitor of the menin-MLL interaction [1]. | |||
T3082 | SGC0946 | Histone Methyltransferase | |
SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells. | |||
T8838 | CCI-007 | Apoptosis , Histone Methyltransferase | |
CCI 007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485 | |||
T12943 | SNDX-5613 | Epigenetic Reader Domain , Histone Methyltransferase | |
SNDX-5613 is a potent and specific inhibitor of Menin-MLL(Ki of 0.149 nM and a cell based IC50 of 10-20 nM). SNDX-5613 can be used for the research of MLL-rearranged (MLL-r) acute leukemias. | |||
T13336 | VTP50469 | Apoptosis , Epigenetic Reader Domain , Histone Methyltransferase | |
VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity. | |||
T6916 | OICR-9429 | OICR 9429 | Histone Methyltransferase , JAK |
OICR-9429 is a potent antagonist of the interaction that WDR5 effect with peptide regions of MLL and Histone 3. It reduces the viability of acute myeloid leukemia cells in vitro. | |||
T28036 | MI-2-2 | MI22,MI 2 2 | Histone Methyltransferase |
MI-2-2 is an inhibitor of bivalent protein-protein interaction between menin and MLL with an IC50 of 46 nM. MI-2-2 binds to menin with Kd of 22 nM. | |||
T69628 | Iptacopan hydrochloride hydrate | ||
Iptacopan hydrochloride hydrate is a highly potent and highly selective factor B inhibitor. | |||
T69581 | NVS MLLT-1 | ||
NVS-MLLT-1 is a selective inhibitor of YEATS domain of MLLT1 and MLLT3. | |||
T12886 | SGC-iMLLT | Histone Methyltransferase | |
SGC-iMLLT is a potent and selective MLLT1/3-histone interactions inhibitor(IC50 = 0.26 μM),and is a first-in-class chemical probe displaying cellular target engagement of MLLT1(Kd = 0.129 μM) and MLLT3(Kd = 0.077 μM). | |||
TQ0069 | MI-503 | Epigenetic Reader Domain , Histone Methyltransferase | |
MI-503 is a highly effective and orally bioavailable inhibitor of the menin-mLL interaction. |